Search

Mild Cognitive Decline Equates to 80% Higher Death Rate
A new study out of the Mayo Clinic assesses the risk of death in patients with mild cognitive decline as compared to individuals with no thinking problems.
Global CV Mortality Rates Increasing
New research evaluated the mortality rates from cardiovascular disease on global populations.
Study Validates “Gold Standard” Alzheimer’s Diagnosis Technique
A team led by UCLA researchers have validated a technique they say is the first “gold standard” for measuring atrophy in the brain’s hippocampus, an early indicator of Alzheimer’s disease.
Hep B surface antigen clearance may not lower HCC risk
By Lorraine L. Janeczko
U.S. new drug approvals slip in 2013 vs prior year
By Reuters Staff(Reuters) - The number of new drugs approved in the United States fell in 2013 compared with the previous year as fewer applications were filed, though several products for hard-to-treat diseases were approved in record time.
Organ donors who need kidneys jump to front of transplant line
By Ronnie Cohen
New guidelines cover all aspects of care for head and neck cancer survivors
By Will Boggs MD
No good evidence on primary care interventions to reduce drug use in children: USPSTF
By Frederik Joelving
Diabetic teens can be easily screened for depression
By MD Will Boggs
Altered cortical anatomy seen in infants with congenital heart disease
By MD Will Boggs
Babies of anxious mothers more likely to cry excessively: study
<p>Women with anxiety disorders may be more likely to have babies who cry excessively, suggests a new German study.</p>
New Oxycodone Formulation Decreased Overdose Rates
Oxycodone overdose rates fell significantly when the high-dose opioid painkiller’s manufacturer switched to an abuse-deterrent formulation in 2010, according to a new study.
How Relevant Is Evidence-Based Medicine to Your Practice?
<div id="article-content-body"> <p>In his recent editorial "Why We Need to Know the Limitations of Evidence-Based Medicine" (CONSULTANT, August 2006, page 963), Dr Gregory Rutecki questioned whether the findings of randomized controlled trials (RCTs) can be extrapolated to patients in primary care practices, who often have multiple comorbidities. A sampling of the feedback we received appears below, along with Dr Rutecki's responses.<br /> &nbsp;</p> </div>
Sofosbuvir-based regimen cost-effective for some hepatitis C virus infections
By Will Boggs MD
Would legalizing medical marijuana help curb the opioid epidemic?
By Ronnie Cohen
Most antibiotics prescribed for sore throat unneeded
<p>Most Americans with a sore throat are prescribed antibiotics even though just a fraction stand to benefit from them, a new study shows.</p>
Trebling tobacco tax 'could prevent 200 million early deaths'
By Kate Kelland
Sleeping problems common in kids with ADHD
<p>Nearly 50% of children with attention-deficit/hyperactivity disorder experience transient sleeping problems, and another 10% have persistent sleeping problems, new research shows.</p>
Naive B-lymphopenia possible biomarker of disease activity in vasculitis
<p>&nbsp;In patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), naive B-lymphopenia may be a biomarker of disease activity, new research suggests.</p>
Antipsychotics appear safe during pregnancy
By David DouglasNEW YORK (Reuters Health) - Use of antipsychotic drugs during pregnancy does not increase the risk of maternal metabolic and other complications, according to Canadian researchers.